Last reviewed · How we verify
Progesterone Vaginal Suppository — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Progesterone Vaginal Suppository (Progesterone Vaginal Suppository) — Assiut University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Progesterone Vaginal Suppository TARGET | Progesterone Vaginal Suppository | Assiut University | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Progesterone Vaginal Suppository CI watch — RSS
- Progesterone Vaginal Suppository CI watch — Atom
- Progesterone Vaginal Suppository CI watch — JSON
- Progesterone Vaginal Suppository alone — RSS
Cite this brief
Drug Landscape (2026). Progesterone Vaginal Suppository — Competitive Intelligence Brief. https://druglandscape.com/ci/progesterone-vaginal-suppository. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing